This article is a correction to:
Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors
Haotian Liu1,2†
Kai Huang3,4,5†
Tao Li6†Tielong Yang1,2Zhichao Liao1,2Chao Zhang1,2Lijie Xiang1,2
Yong Chen3,4*
Jilong Yang1,2*- 1Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
- 2National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
- 3Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
- 4Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
- 5Brandon Regional Hospital GME, HCA Healthcare/USF Morsani College of Medicine, Brandon, FL, United States
- 6Department of Bone and Soft-Tissue Tumor, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China
By Liu H, Huang K, Li T, Yang T, Liao Z, Zhang C, Xiang L, Chen Y, Yang J (2021). Front Oncol. Feb 25;11:634648. doi: 10.3389/fonc.2021.634648
In the original article, there was an error in the Results section of the Abstract: “Among these patients, 53 experienced recurrence, with a recurrence rate of 20.15%”.
A correction has been made to the Results section of the Abstract: “Among these patients, 53 experienced recurrence, with a recurrence rate of 19.85%”.
In the original article, there was an error in Patient Outcomes and Risk Factors Associated With RFS of the Results: “Among the 267 patients, 53 patients (20.15%) experienced recurrence”.
A correction has been made to Results, Patient Outcomes and Risk Factors Associated With RFS, Paragraph 1: “Among the 267 patients, 53 patients (19.85%) experienced recurrence”.
The authors apologize for these errors and state that these do not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: desmoid tumor, recurrence, prediction, the web-based nomogram, tumor number, validation
Citation: Liu H, Huang K, Li T, Yang T, Liao Z, Zhang C, Xiang L, Chen Y and Yang J (2021) Corrigendum: Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors. Front. Oncol. 11:688620. doi: 10.3389/fonc.2021.688620
Received: 31 March 2021; Accepted: 31 March 2021;
Published: 20 April 2021.
Copyright © 2021 Liu, Huang, Li, Yang, Liao, Zhang, Xiang, Chen and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yong Chen, chenyong@fudan.edu.cn; Jilong Yang, yangjilong@tjmuch.com
†These authors have contributed equally to this work